Citation 79351

TAKAISHI,Y: WARIISHI,N: TATEISHI,H: KAWAZOE,K: NAKANO,K: ONO,Y: TOKUDA,H: NISHINO,H: IWASHIMA,A:. (1997). TRITERPENOID INHIBITORS OF INTERLEUKIN-1-SECRETION AND TUMOUR-PROMOTION FROM TRIPTERYGIUM WILFORDII VAR.REGELII.. 45(5)

Citation Details

Title	TRITERPENOID INHIBITORS OF INTERLEUKIN-1-SECRETION AND TUMOUR-PROMOTION FROM TRIPTERYGIUM WILFORDII VAR.REGELII.
Authors	TAKAISHI,Y: WARIISHI,N: TATEISHI,H: KAWAZOE,K: NAKANO,K: ONO,Y: TOKUDA,H: NISHINO,H: IWASHIMA,A:
Year	1997
Volume	45
Issue	5

Summary

Year: 1997

Journal: Unknown

Organisms and Their Experiments (1)

Tripterygium wilfordii (CELASTRACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	REGEOL A	None
2	INTERLEUKIN-1-ALPHA RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	REGEOL A	ACTIVE
3	INTERLEUKIN-1-BETA RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	REGEOL A	ACTIVE
4	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	REGEOL B	None
5	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	REGEOL C	None
6	EARLY ANTIGEN VIRAL INDUCTION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	REGEOL B	ACTIVE
7	INTERLEUKIN-1-ALPHA RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	REGEOL B	INACTIVE
8	INTERLEUKIN-1-BETA RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	REGEOL B	INACTIVE
9	EARLY ANTIGEN VIRAL INDUCTION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	REGEOL C	ACTIVE
10	INTERLEUKIN-1-ALPHA RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	REGEOL C	INACTIVE
11	INTERLEUKIN-1-ALPHA RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	REGEOL C	INACTIVE
12	Not specified	UV SPECTRUM GIVEN FORISOLATION AND IDENTIFICATION OFPMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATA	TINGENONE,22-BETA-HYDROXY:	None
13	Not specified	UV SPECTRUM GIVEN FORISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATA	WILFOROL A	None
14	EARLY ANTIGEN VIRAL INDUCTION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	TINGENONE,22-BETA-HYDROXY:	WEAK ACTIVITY
15	INTERLEUKIN-1-ALPHA RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	TINGENONE,22-BETA-HYDROXY:	ACTIVE
16	INTERLEUKIN-1-BETA RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	TINGENONE,22-BETA-HYDROXY:	ACTIVE
17	EARLY ANTIGEN VIRAL INDUCTION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	WILFOROL A	ACTIVE
18	INTERLEUKIN-1-ALPHA RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	WILFOROL A	INACTIVE
19	INTERLEUKIN-1-BETA RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	WILFOROL A	INACTIVE
20	Not specified	ISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FOR	REGELIDE	None
21	Not specified	ISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATA	SALASPERMIC ACID	None
22	EARLY ANTIGEN VIRAL INDUCTION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	REGELIDE	ACTIVE
23	INTERLEUKIN-1-ALPHA RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	REGELIDE	INACTIVE
24	INTERLEUKIN-1-BETA RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	REGELIDE	INACTIVE
25	Not specified	ISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATA	ORTHOPHENIC ACID	None
26	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	CELASTROL	None
27	EARLY ANTIGEN VIRAL INDUCTION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CELASTROL	ACTIVE
28	INTERLEUKIN-1-ALPHA RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CELASTROL	ACTIVE
29	INTERLEUKIN-1-BETA RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CELASTROL	ACTIVE
30	Not specified	ISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATA	DULCIOIC ACID	None
31	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	KATONONIC ACID METHYL ESTER	None
32	Not specified	ISOLATION AND IDENTIFICATION OF	REGELIN,DEMETHYL:	None
33	EARLY ANTIGEN VIRAL INDUCTION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	REGELIN,DEMETHYL:	ACTIVE
34	INTERLEUKIN-1-ALPHA RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	REGELIN,DEMETHYL:	ACTIVE
35	INTERLEUKIN-1-BETA RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	REGELIN,DEMETHYL:	ACTIVE

Citation 79351

Citation Details

Summary

Organisms and Their Experiments (1)

Tripterygium wilfordii (CELASTRACEAE)

Show SPARQL Queries (1)

Query 1